{"version":"1.0","type":"rich","provider_name":"Everlit","provider_url":"https://everlit.audio/","title":"Opinion: The case for ending Kentucky’s prohibition on Medicaid coverage for weight loss drugs","description":"Kentucky debates lifting the Medicaid ban on GLP-1 weight loss drugs. Proponents argue that coverage improves public health, saves billions in long-term costs, and fulfills the Obesity Bill of Rights.","author_name":"LINK NKY","thumbnail_url":"https://cdn.everlit.audio/covers/artl_6PEgDS666YK/2f407970-1bf1-46a8-a75d-ca3a65add6a4/small.png","width":480,"height":136,"html":"\u003ciframe title=\"Opinion: The case for ending Kentucky’s prohibition on Medicaid coverage for weight loss drugs\" src=\"https://everlit.audio/embeds/artl_6PEgDS666YK\" width=\"100%\" height=\"136px\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" allowfullscreen\u003e\u003c/iframe\u003e"}